Skip to main content
PAVmed Inc. logo

PAVmed Inc. — Investor Relations & Filings

Ticker · PAVM ISIN · US70387R1068 LEI · 549300V1JXXVXU7P8007 US Professional, scientific and technical activities
Filings indexed 648 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country US United States of America
Listing US PAVM

About PAVmed Inc.

https://pavmed.com/

PAVmed Inc. is a commercial-stage, diversified medical technology company that develops and commercializes products across the medical device, diagnostics, and digital health sectors. The company operates through a shared-services business model to support its majority-owned subsidiaries. Its key subsidiary, Lucid Diagnostics, offers the EsoGuard® Esophageal DNA Test, a diagnostic tool for the early detection of esophageal precancer. Another subsidiary, Veris Health, provides a digital health platform for remote patient monitoring to enhance personalized cancer care. PAVmed's strategy focuses on acquiring and developing early-stage medical technologies to address unmet clinical needs for patients and healthcare systems.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-15 English
FORM 10-Q
Interim / Quarterly Report
2026-05-14 English
DEF 14A - PAVmed Inc. (0001624326) (Filer)
Proxy Solicitation & Information Statement
2026-05-01 English
ARS - PAVmed Inc. (0001624326) (Filer)
Annual Report
2026-04-30 English
8-K - PAVmed Inc. (0001624326) (Filer)
Regulatory Filings
2026-03-30 English
10-K - PAVmed Inc. (0001624326) (Filer)
Annual Report FY 2025
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.